[{"Assets_0_Q3_USD":474449000.0,"CommonStockSharesOutstanding_0_Q3_shares":53333211.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":36156000.0,"NetIncomeLoss_1_Q3_USD":100423000.0,"NetIncomeLoss_3_Q3_USD":111337000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":53297298.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":53052521.0,"StockholdersEquity_0_Q3_USD":400907000.0,"EarningsPerShareBasic_1_Q3_USD":1.88,"EarningsPerShareBasic_3_Q3_USD":2.1,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]